nsclc, stage iiia

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC Stage II, NSCLC, Stage IIIA Trial in Goyang-si (Erlotinib)

Active, not recruiting
  • NSCLC Stage II
  • NSCLC, Stage IIIA
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

NSCLC, Stage IIIA, EGF-R Negative NSCLC, ALK Negative NSCLC Trial in Shanghai (PD-1 and chemo)

Recruiting
  • NSCLC, Stage IIIA
  • +2 more
  • PD-1 and chemotherapy
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Dec 14, 2021

NSCLC Stage II, NSCLC, Stage IIIA, NSCLC Stage IIIB Trial in Heidelberg (Atezolizumab)

Recruiting
  • NSCLC Stage II
  • +2 more
  • Heidelberg, BaWü, Germany
    Thoraxklinik Heidelberg gGmbH
Apr 25, 2021

Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Tampa (dietary supplement, radiation, drug, other)

Withdrawn
  • Non Small Cell Lung Cancer
  • +6 more
  • Impact® Advanced Recovery
  • +6 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 9, 2020